BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6174158)

  • 1. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic-like and antipsychotic effects of gamma-type endorphins.
    Van Ree JM; Verhoeven WM; Van Praag HM; De Wied D
    Mod Probl Pharmacopsychiatry; 1981; 17():266-78. PubMed ID: 6173744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endorphins of the gamma type in the treatment of schizophrenic psychoses].
    Verhoeven WM; Van Ree JM
    Acta Psychiatr Belg; 1984; 84(2):160-72. PubMed ID: 6204507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients.
    Emrich HM; Zaudig M; Kissling W; Dirlich G; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):290-8. PubMed ID: 7003611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of the synthetic peptides gamma-type endorphins in mentally ill patients.
    van Ree JM; Verhoeven WM; de Wied D; van Praag HM
    Ann N Y Acad Sci; 1982; 398():478-95. PubMed ID: 6186176
    [No Abstract]   [Full Text] [Related]  

  • 7. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM; Westenberg HG; Gerritsen TW; van Praag HM; Thijssen JH; Schwarz F; van Ree JM; de Wied D
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotic efficacy of neuroleptic neuropeptides in schizophrenia. Review of clinical data].
    Verhoeven VM
    Encephale; 1987; 13(6):349-56. PubMed ID: 2453339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro.
    Nijkamp FP; van Ree JM; Nijssen JG; Versluis M; de Wied D
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):213-7. PubMed ID: 6185856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-opiate effects of neuropeptides derived from beta-endorphin.
    De Wied D; Van Ree JM
    Pol J Pharmacol Pharm; 1987; 39(5):623-32. PubMed ID: 2976164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of [Des-Tyr1]-gamma-endorphin in schizophrenia.
    Emrich HM; Zaudig M; v Zerssen D; Kissling W; Dirlich G; Herz A
    Mod Probl Pharmacopsychiatry; 1981; 17():279-86. PubMed ID: 7329421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Etiologic and therapeutic significance of endorphins in endogenous psychoses].
    Naber D
    Nervenarzt; 1983 Nov; 54(11):573-7. PubMed ID: 6318141
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endogenous opioids and gamma type endorphins in schizophrenia].
    Verhoeven WM
    Arch Neurobiol (Madr); 1983; 46(5):335-8. PubMed ID: 6362599
    [No Abstract]   [Full Text] [Related]  

  • 14. Endorphin research in schizophrenic psychoses.
    Van Praag HM; Verhoeven WM
    Compr Psychiatry; 1981; 22(2):135-46. PubMed ID: 6260424
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients.
    Verhoeven WM; van Ree JM; Heezius-van Bentum A; de Wied D; van Praag HM
    Arch Gen Psychiatry; 1982 Jun; 39(6):648-54. PubMed ID: 7092498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic studies of beta-endorphin in psychopathology.
    Berger PA; Barchas JD
    Psychiatr Clin North Am; 1983 Sep; 6(3):377-91. PubMed ID: 6316299
    [No Abstract]   [Full Text] [Related]  

  • 17. Hla, and the response to treatment with gamma-type endorphins in schizophrenia.
    de Jongh BM; Verhoeven WM; van Ree JM; de Wied D; van Rood JJ
    J Immunogenet; 1982 Dec; 9(6):381-8. PubMed ID: 6186747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of des-tyrosine-gamma-endorphin in tardive dyskinesia.
    Casey DE; Korsgaard S; Gerlach J; Jørgensen A; Simmelsgaard H
    Arch Gen Psychiatry; 1981 Feb; 38(2):158-60. PubMed ID: 7011248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endogenous opiates and schizophrenia. Treatment of acute schizophrenic psychoses with beta-endorphin].
    Pethö B; Gráf L; Karczag I; Borvendég J; Bitter I; Barna I; Hermann I; Tolna J; Baraczka K
    Orv Hetil; 1980 Sep; 121(38):2307-11. PubMed ID: 6258124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.